Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Spruce Biosciences Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a 389.05% increase from the last price of 0.5112.
High | 486.9% | 3.00 |
Med | 389.0% | 2.50 |
Low | 291.2% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 11, 2025.
Average growth rate | +7.33% |
Average growth rate | +30.58% |
More ▼
Revenue history & estimates in USD
Average growth rate | -29.72% |
Average growth rate | 0.00% |
More ▼